<DOC>
	<DOCNO>NCT00257010</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety almotriptan malate ( migraine headache medication ) treatment migraine headaches adolescent one year .</brief_summary>
	<brief_title>A 1-year Study Adolescents Assess Long-term Safety Almotriptan Malate When Treating Their Migraine Headaches</brief_title>
	<detailed_description>Almotriptan malate , several treatment migraine headache , know triptans , approve treatment migraine headache adult . To date , none approve Food Drug Administration ( FDA ) use adolescent . This open-label , multi-center study enroll approximately 450 patient age 12 - 17 year old history one 14 migraine per month 6 month prior enter study . The total study duration one year . There screen phase determine patient eligible study entry , follow open-label treatment phase last one year . Almotriptan malate 12.5 mg tablet use treat migraine headache study , need . The primary outcome study assessment long-term safety almotriptan malate adolescent migraine sufferer . The study hypothesis almotriptan malate safe well tolerate treatment adolescent migraine headache . Safety measurement perform set time point study include laboratory test , physical neurological exam , electrocardiogram ( ECGs ) incidence adverse event . A diary complete patient migraine headache take almotriptan malate . Migraine pain information almotriptan malate use record headache diary . An equal number patient 12 - 14 year old range 15 - 17 year old range enrol . Patients take one 12.5 mg almotriptan malate tablet mouth onset migraine headache pain . The dose may repeat pain continue 2 hour first dose , 2 dos take within 24-hour period . Study medication take one year .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Almotriptan</mesh_term>
	<criteria>Have history migraine least one year Have average 1 14 migraine per month 6 month prior study entry Able swallow oral medication Able complete headache diary Only take one migraine preventive medication dose medication least 30 day enter study ) Have allergy almotriptan malate stop take almotriptan malate due side effect Have 15 day within month headache Usually experience migraine aura ( common symptom visual disturbance tingle sensation migraine pain begin ) without headache Experience 6 nonmigraine headache per month</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Almotriptan Malate</keyword>
	<keyword>Headache</keyword>
	<keyword>Triptan</keyword>
</DOC>